Becton Dickinson and Co
NYSE:BDX
Becton Dickinson and Co
NYSE:BDX
Price:
240.35 USD
2.84%
Market Closed
Updated:
May 3, 2024
Becton Dickinson and Co
Revenue
|
Becton Dickinson and Co
Revenue Peer Comparison
Comparables:
BSX
EW
SYK
ABT
ISRG
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.7B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Revenue
$6.1B
|
CAGR 3-Years
11%
|
CAGR 5-Years
10%
|
CAGR 10-Years
11%
|
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$21B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
Becton Dickinson and Co
Revenue Breakdown
Breakdown by Geography
Becton Dickinson and Co
Becton Dickinson and Co
|
Total Revenue:
19.4B
USD
|
|
United States:
11.1B
USD
|
|
Non-Us:
8.3B
USD
|
|
EMEA:
4.2B
USD
|
|
Greater Asia:
2.9B
USD
|
|
Other:
1.1B
USD
|
Breakdown by Segments
Becton Dickinson and Co
Becton Dickinson and Co
Not Available
See Also
What is Becton Dickinson and Co's Revenue?
Revenue
19.5B
USD
19.5B
USD
Based on the financial report for Dec 31, 2023, Becton Dickinson and Co's Revenue amounts to 19.5B USD.
What is Becton Dickinson and Co's Revenue growth rate?
Revenue CAGR 10Y
9%
9%
Over the last year, the Revenue growth was 4%. The average annual Revenue growth rates for Becton Dickinson and Co have been 4% over the past three years , 3% over the past five years , and 9% over the past ten years .
You don't have any saved screeners yet
